GlassScriptPhysician profile
Sarah Danehower
NPI 1700465150
$1,844.31
in general payments reported to CMS, 2019-2025
9 companies · $892 in 2025
The $892 reported for 2025 was more than what a typical Neurological Surgery provider received nationally (typical 2025 total: $604).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $487 · 2022: $48.28 · 2023: $20.85 · 2024: $397 · 2025: $892.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,309.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,309.10 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $642.00 | 2021-2025 | Strata, Duet, Mazor X System |
| Stryker Corporation | $337.02 | 2021-2024 | N/A, Duramatrix |
| Gt Medical Technologies, INC | $292.23 | 2025 | Gammatile |
| Baxter Healthcare | $189.64 | 2024-2025 | Floseal |
| Depuy Synthes Sales INC. | $158.53 | 2025 | Vivigen Mis Delivery System |
| Ethicon US, LLC | $144.44 | 2025 | Evarrest, Stratafix |
| Novocure INC. | $44.33 | 2023-2024 | Optune |
| Lemaitre Vascular, INC. | $24.53 | 2024 | Anastoclip Gc 8cm (Medium) |
| Irras USA, INC. | $11.59 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sarah Danehower listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.